Kably AA, Estévez GS, Carballo ME

Language: Spanish
References: 8
Page: 197-201
PDF size: 386.98 Kb.

ABSTRACT

Background: Since the beginning of assisted reproductive technologies, they have been in search of a pregnancy predictor, mainly in in vitro fertilization, due to its difficulty and expensiveness.
Objective: To know if there is an optimal estradiol levels to reach pregnancy in patients with in vitro fertilization and embryo transference.
Material and methods: Retrospective and descriptive study of 179 patients in the fresh in vitro fertilization cycles from January 1 to December 31, 2006. Patients were grouped by serum estradiol level the day before of hCG administration: Group 1, ‹1,000; Group 2, 1,001-1,500; Group 3, 1,501-2,000; Group 4, 2,001-2,500; Group 5, 2,501-3,000, and Group 6, › 3,000 pg/dL. Pearson’s chi-square and ANOVA, with Stata, were used to determine whether E2 levels were associated with oocyte number, quality, maturation and pregnancy rates.
Results: A significant difference was noted in the number of MII oocytes retrieved and pregnancy rates, but there is no relation with E2 levels. Higher pregnancy rate was at Group 1, where older patients were too.
Conclusions: Estradiol level before hCG administration is not a predictor factor of pregnancy rates, nor even determinant of oocyte retrieval cancellation in patients with in vitro fertilization and embryo transference, mostly in advanced age patients.

REFERENCES

1. American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 2002;78(5):918-31.

2. International Committee for Monitoring Assisted Reproductive Technology. Adamson GD, de Mouzon J, Lancaster P, Nygren KG, Sullivan E, Zegers-Hochschild F. World collaborative report on in vitro fertilization, 2000. Fertil Steril 2006;85(6):1586-622.

3. Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperestimulation syndrome (OHSS). Hum Reprod 2003;9:77-96.

4. Kably A, Castelazo E, Barroso G. Comparative analysis of multifollicular development with the application of recombinant FSH vs urinary FSH in the results of in vitro fertilization. Ginecol Obstet Mex 2001;69:304-9.

5. Agard J, Glujovsky D, Shamonki MI, Frattarelli J, Bergh PA. Estradiol levels after human chorionic gonadotropin (hCG) administration are not predictive of IVF outcome: analysis of 7,474 initial fresh IVF cycles. Fertil Steril 2007;88:S125.

6. Melissa D, Chiasson G, Wright B, Randal D, Robinson N, Props A. Measuring estradiol levels alter human chorionic gonadotropin administration for in vitro fertilization is not clinically useful. Fertil Steril 2007;87:448-50.

7. Jurema M, Blazar A. Estradiol level on day of hCG does not correlate with pregnancy rate in GnRH antagonist IVF-ET cycles. Fertil Steril 2005;84:S274-5.

8. Telmo B, Acacio M, Nouriani. Peak serum estradiol (E2) is a predictor of pregnancy outcome in in vitro fertilization. Fertil Steril 2006;S231.